Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
2.810
+0.050 (1.81%)
Mar 6, 2026, 9:00 AM EDT - Market open
Immutep Market Cap
Immutep has a market cap or net worth of $408.45 million as of March 9, 2026. Its market cap has increased by 39.21% in one year.
Market Cap
408.45M
Enterprise Value
339.74M
1-Year Change
39.21%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since April 19, 2012, Immutep's market cap has increased from $74.60M to $408.45M, an increase of 447.52%. That is a compound annual growth rate of 13.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 406.70M | -2.63% |
| Dec 31, 2025 | 417.70M | 32.52% |
| Dec 31, 2024 | 315.20M | 10.60% |
| Dec 29, 2023 | 285.00M | 87.99% |
| Dec 30, 2022 | 151.60M | -38.22% |
| Dec 31, 2021 | 245.40M | 60.29% |
| Dec 31, 2020 | 153.10M | 152.22% |
| Dec 31, 2019 | 60.70M | 8.98% |
| Dec 31, 2018 | 55.70M | 70.34% |
| Dec 29, 2017 | 32.70M | 125.52% |
| Dec 30, 2016 | 14.50M | -27.50% |
| Dec 31, 2015 | 20.00M | 143.90% |
| Dec 31, 2014 | 8.20M | -29.91% |
| Dec 31, 2013 | 11.70M | -68.03% |
| Dec 31, 2012 | 36.60M | -50.94% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 414.45M |
| Upstream Bio | 413.94M |
| DiaMedica Therapeutics | 413.09M |
| Niagen Bioscience | 406.05M |
| NovaBridge Biosciences | 403.52M |
| Autolus Therapeutics | 401.88M |
| Crescent Biopharma | 400.89M |
| PureTech Health | 400.20M |